Modulation of purinergic signaling by NPP-type ectophosphodiesterases

Purinergic Signalling

Volumn 2, Issue 2, 2006, Pages 361-370

  Stefan, Cristiana ^a,b   Jansen, Silvia ^a   Bollen, Mathieu ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Campus Gasthuisberg Univ of Leuven   (Belgium)

Author keywords

Alkaline sphingomyelinase; Ectonucleotide pyrophosphatase; Ectophosphodiesterase; ENPP; Lysophospholipase D; NPP; NPP type ectophosphodiesterase

Indexed keywords

EID: 34548012770     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-005-5303-4     Document Type: Review

References (99)

1. Boeynaems JM, Communi D, Gonzalez NS, Robaye B. Overview of the P2 receptors. Semin Thromb Hemost 2005;31:139-49.
2. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22: 364-73.364-73.
3. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clin Med 2002;2:45-53.
4. Sak K, Boeynaems JM, Everaus H. Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol 2003;73:442-7.
5. Agresti C, Meomartini ME, Amadio S et al. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: Involvement of metabotropic P2 receptors. Brain Res Rev 2005;48:157-65.
6. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003;64:785-95.
7. Yegutkin GG, Henttinen T, Jalkanen S. Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J 2001;15:251-60.
8. Donaldson SH, Picher M, Boucher RC. Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 2002;26:209-15.
9. Picher M, Boucher RC. Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces. J Biol Chem 2003;278:11256-64.
10. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedebergs Arch Pharmacol 2000; 362: 299-309.
11. Kunapuli SP, Dorsam RT, Kim S, Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 2003;3:175-80.
12. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004;113:340-5.
13. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 2005;5:712-21.
14. Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol 2005;35:25-30.
15. Adair TH. Growth regulation of the vascular system: An emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 2005;289:R283-96.
16. Sevigny J, Sundberg C, Braun N et al. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 2002;99:2801-9.
17. Heine P, Braun N, Heilbronn A et al. Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur J Biochem 1999;262:102-7.
18. Bollen M, Gijsbers R, Ceulemans H, Stefan C. Nucleotide pyrophosphatase/ phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000;35:393-432.
19. Vollmayer P, Clair T, Goding JW et al. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases. Eur J Biochem 2003;270:2971-8.
20. Duan RD, Bergman T, Xu N et al. Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem 2003;278:38528-36.
21. Wu J, Cheng Y, Palmberg C et al. Cloning of alkaline sphingomyelinase from rat intestinal mucosa and adjusting of the hypothetical protein XP_221184 in GenBank. Biochim Biophys Acta 2005;1687:94-102.
22. Sakagami H, Aoki J, Natori Y et al. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/ phosphodiesterase family. J Biol Chem 2005;280:23084-93.
23. Umezu-Goto M, Kishi Y, Taira A et al. Autotaxin has lysophospholipase D activity leading to tumour cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002;158:227-33.
24. Tokumura A, Majima E, Kariya Y et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002;277:39436-42.
25. Wu J, Liu F, Nilsson A et al. Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gasterointest Liver Physiol 2004;287:G967-73.
26. Belli SI, van Driel IR, Goding JW. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase). Eur J Biochem 1993; 217: 421-8.
27. Hosoda N, Hoshino SI, Kanda Y, Katada T. Inhibition of phosphodiesterase/ pyrophosphatase activity of PC-1 by its association with glycosaminoglycans. Eur J Biochem 1999;265:763-70.
28. Meerson NR, Delautier D, Durand-Schneider AM et al. Identification of B10, an alkaline phosphodiesterase of the apical plasma membrane of hepatocytes and biliary cells, in rat serum: Increased levels following bile duct ligation and during the development of cholangiocarcinoma. Hepatology 1998;27:563-8.
29. Yegutkin GG, Samburski SS, Jalkanen S. Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J 2003;17:1328-30.
30. Jansen S, Stefan C, Creemers JW et al. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci 2005;118:3081-9.
31. Goding JW, Grobben B, Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 2003;1638:1-19.
32. Stefan C, Jansen S, Bollen M. NPP-type ectophosphodiesterases: Unity in diversity. Trends Biochem Sci 2005;30:542-50.
33. Galperin MY, Bairoch A, Koonin EV. A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases. Prot Sci 1998;7:1829-35.
34. Gijsbers R, Ceulemans H, Stalmans W, Bollen M. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem 2001;276:1361-8.
35. Vaingankar SM, Fitzpatrick TA, Johnson K et al. Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1. Am J Physiol Cell Physiol 2004;286:C1177-87.
36. Meerson NR, Bello V, Delaunay JL et al. Intracellular traffic of the ecto-nucleotide pyrophosphatase/phosphodiesterase NPP3 to the apical plasma membrane of MDCK and Caco-2 cells: Apical targeting occurs in the absence of N -glycosylation. J Cell Sci 2000;113:4193-202.
37. Gijsbers R, Ceulemans H, Bollen M. Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/ phosphodiesterase NPP1. Biochem J 2003;371:321-30.
38. Zhou A, Huntington JA, Pannu NS et al. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol 2003;10:541-4.
39. Cimpean A, Stefan C, Gijsbers R et al. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2. Biochem J 2004;381:71-7.
40. Fox MA, Alexander JK, Afshari FS et al. Phosphodiesterase-I alpha/ autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci 2004;27:140-50.
41. Frohman MA, Sung TC, Morris AJ. Mammalian phospholipase D structure and regulation. Biochim Biophys Acta 1999;1439:175-86.
42. Grupe A, Alleman J, Goldfine ID et al. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 1995;270:22085-8.
43. Stefan C, Wera S, Stalmans W, Bollen M. The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes 1996;45:980-3.
44. Hessle L, Johnson KA, Anderson HC et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002;99:9445-9.
45. Rutsch F, Ruf N, Vaingankar S et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003;34:379-81.
46. Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol 2004;555:311-21.
47. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta 2003;1615:7-32.
48. Klepeis VE, Weinger I, Kaczmarek E, Trinkaus-Randall V. P2Y receptors play a critical role in epithelial cell communication and migration. J Cell Biochem 2004;93:1115-33.
49. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: Established and potential clinical applications. Drugs 1999;58:211-32.
50. Kellerman DJ. P2Y(2) receptor agonists: A new class of medication targeted at improved mucociliary clearance. Chest 2002;121:201S-5S.
51. Picher M, Burch LH, Boucher RC. Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis. J Biol Chem 2004;279:20234-41.
52. Lazarowski ER, Tarran R, Grubb BR et al. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 2004;279:36855-64.
53. Taira M, Tamaoki J Nishimura K et al. Adenosine A(3) receptor-mediated potentiation of mucociliary transport and epithelial ciliary motility. Am J Physiol Lung Cell Mol Physiol 2002;282:L556-62.
54. Picher M, Boucher RC. Biochemical evidence for an ectoalkaline phosphodiesteraseI in human airways. Am J Respir Cell Mol Biol 2000;23:255-61.
55. Picher M, Boucher RC. Metabolism of extracellular nucleotides in human airways by a multienzyme system. Drug Dev Res 2001;52:66-75.
56. Stefan C, Gijsbers R, Stalmans W, Bollen M. Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver. Biochim Biophys Acta 1999;1450:45-52.
57. Laubinger W, Wang H, Welte T et al. P2Y receptor specific for diadenosine tetraphosphate in lung: Selective inhibition by suramin, PPADS, Ip5I, and not by MRS-2197 Eur J Pharmacol 2003;468:9-14.
58. Picher M, Burch LH, Hirsh AJ et al. Ecto 5′-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 2003; 278:13468-79.
59. Che M, Gatmaitan Z, Arias IM. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. FASEB J 1997;11:101-8.
60. Hirata K, Nathanson MH. Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver. Gastroenterology 2001;121:396-406.
61. Gatof D, Kilic G, Fitz JG. Vesicular exocytosis contributes to volume-sensitive ATP release in biliary cells. Am J Physiol Gasterointest Liver Physiol 2004;286:G538-46.
62. Scott LJ, Delautier D, Meerson NR et al. Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes. Hepatology 1997;25:995-1002.
63. Yano Y, Hayashi Y, Sano K et al. Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases. Cancer Lett 2004;207:139-147.
64. Salter KD, Fitz JG, Roman RM. Domain-specific purinergic signaling in polarized rat cholangiocytes. Am J Physiol Gasterointest Liver Physiol 2000;278:G492-500.
65. Dranoff JA, Kruglov EA, Robson SC et al. The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 2002;36:1135-44.
66. Jhandier MN, Kruglov EA, Lavoie EG et al. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 2005;280:22986-92.
67. Scoazec JY, Moreau A, Maurice M et al. Detection of a biliary cell membrane glycoprotein in the serum of cholangiocarcinoma-bearing rats. Possible relevance to the membrane proteins used as serum tumour markers in humans. Lab Invest 1990;62:459-66.
68. Thevananther S, Sun H, Li D, Arjunan V et al. Extracellular ATP activates c- Jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 2004;39:393-402.
69. Stefan C, Stalmans W, Bollen M. Growth-related expression of the ectonucleotide pyrophosphatase PC-1 in rat liver. Hepatology 1998;28:1497-503.
70. Aggett P, Leach JL, Rueda R et al. Innovation in infant formula development: A reassessment of ribonucleotides in 2002. Nutrition 2003;19:375-84.
71. Synnestvedt K, Furuta GT, Comerford KM et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002;110:993-1002.
72. Neary JT, Kang Y, Shi YF. Signaling from nucleotide receptors to protein kinase cascades in astrocytes. Neurochem Res 2004;29:2037-42.
73. Koizumi S, Fujishita K, Inoue K. Regulation of cell-to-cell communication mediated by astrocytic ATP in the CNS. Purinergic Signalling 2005;1:211-7.
74. Franke H, Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 2006;109:297-324.
75. Agresti C, Meomartini ME, Amadio S et al. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development. Glia 2005;50:132-44.
76. Fuss B, Baba H, Phan T et al. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci 1997;17:9095-103.
77. Blass-Kampmann S, Kindler-Rohrborn A, Deissler H et al. In vitro differentiation of neural progenitor cells from prenatal rat brain: Common cell surface glycoprotein on three glial cell subsets. J Neurosci Res 1997; 48: 95-111.
78. Xiang Z, Burnstock G. Expression of P2X receptors in rat choroid plexus. Neuroreport 2005;16:903-07.
79. Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 2004;129:957-70.
80. Sato K, Malchinkhuu E, Muraki T et al. Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem 2005;92:904-14.
81. Hammack BN, Fung KY, Hunsucker SW et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 2004;10:245-60.
82. Fox MA, Colello RJ, Macklin WB, Fuss B. Phosphodiesterase-Ialpha/ autotaxin: A counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci 2003; 23: 507-519.
83. Deissler H, Blass-Kampmann S, Bruyneel E et al. Neural cell surface differentiation antigen gp130(RB13-6) induces fibroblasts and glioma cells to express astroglial proteins and invasive properties. FASEB J 1999;13:657-66.
84. Grobben B, Anciaux K, Roymans D et al. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 1999;72:826-34.
85. Grobben B, Claes P, Roymans D et al. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists. Br J Pharmacol 2000;130:139-45.
86. Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 2002;310:257-270.
87. Anderson KC, Bates MP, Slaughenhoupt B et al. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol 1984;132:3172-9.
88. Deterre P, Gelman L, Gary-Gouy H et al. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J Immunol 1996;157:1381-8.
89. Seman M, Adriouch S, Scheuplein F et al. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003;19:571-82.
90. Krebs C, Adriouch S, Braasch F et al. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J Immunol 2005;174:3298-305.
91. Bortell R, Moss J, McKenna RC et al. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: Role of cell surface NAD glycohydrolase and pyrophosphatase activities. J Immunol 2001;167:2049-59.
92. Popoff MR. Interactions between bacterial toxins and intestinal cells. Toxicon 1998;36:665-85.
93. Moolenaar WH. Lysophospholipids in the limelight: Autotaxin takes center stage. J Cell Biol 2002;158:197-9.
94. Spychala J. Tumour-promoting functions of adenosine. Pharmacol Ther 2000;87:161-73.
95. Cronstein BN. Adenosine receptors and wound healing. Sci World J 2004;4:1-8.
96. Desai A, Victor-Vega C, Gadangi S et al. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol. 2005; 67: 1406-13.
97. Tice DA, Szeto W, Soloviev I et al. Synergistic induction of tumour antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 2002;277:14329-35.
98. Kenny PA, Enver T, Ashworth A. Receptor and secreted targets of Wnt-1/ beta-catenin signaling in mouse mammary epithelial cells. BMC Cancer 2005;5:3-11.
99. Spychala J, Kitajewski J. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Exp Cell Res 2004;296:99-108.